SUNPHARMA vs ULTRACEMCO: Stock Comparison
SUN PHARMACEUTICAL IND L is the larger company by market capitalisation. SUN PHARMACEUTICAL IND L shows a lower P/E, a higher ROE and faster revenue growth, while ULTRATECH CEMENT shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
SUNPHARMA leads 7; ULTRACEMCO leads 4 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| Sector | Healthcare | Construction Materials |
| Industry | Pharmaceuticals | Cement & Cement Products |
Price
| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| Live Price | ₹1,748 | ₹11,050 |
| Day Change | -0.57% | 0.84% |
| Volume | 10.65 L | 3.04 L |
| 52-Week High | ₹2,046.9 | ₹13,110 |
| 52-Week Low | ₹1,583.7 | ₹10,325 |
| Distance from 52W High | -14.6% | -15.71% |
Valuation
| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| Market Cap | ₹4.18 L Cr | ₹3.26 L Cr |
| P/E Ratio | 34.58x | 37.05x |
| P/B Ratio | 5x | 4.43x |
| EPS | ₹12.06 | ₹88.21 |
| Book Value | ₹349.6 | ₹2,738.99 |
| Dividend Yield | 0.92% | 2.17% |
Growth
| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| Revenue Growth (TTM YoY) | 12.8% | 3% |
| EPS Growth (TTM YoY) | 25.6% | 45.3% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| ROE | 13.72% | 10.15% |
| ROCE | 15.16% | 9.32% |
| Net Margin | 18.56% | 10.24% |
| Operating Margin | 26.44% | 14.48% |
| Debt to Equity | 0.05x | 0.28x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | SUNPHARMA | ULTRACEMCO |
|---|---|---|
| Promoter Holding | 52.68%▼ 1.8 pp | 57.55%▼ 0.85 pp |
| FII Holding | 14.36%▼ 0.17 pp | 12.69%▼ 0.17 pp |
| DII Holding | 22.27%▲ 0.09 pp | 20.86%▲ 1.17 pp |
| Public Holding | 10.7%▲ 1.89 pp | 7.71%▼ 0.2 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: SUN PHARMACEUTICAL IND L and ULTRATECH CEMENT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.